Ardsley Advisory Partners’s GeneDx Holdings WGS Stock Holding History

Ardsley Advisory Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.15M	Sell	75,000 -25,000	-25%	-$1.42M	0.54%	59
2026 Q1	$6.42M	Buy	100,000 +45,000	+82%	+$4.1M	0.82%	38
2025 Q4	$7.15M	Sell	55,000 -5,000	-8%	-$686K	0.79%	46
2025 Q3	$6.46M	Sell	60,000 -20,000	-25%	-$2.18M	0.8%	43
2025 Q2	$7.38M	Buy	+80,000	New	+$6.28M	0.97%	33

Other funds holding WGS

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HAM

Harmony Asset Management Scottsdale, Arizona $372M AUM 37.39% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Ardsley Advisory Partners's WGS Position: Q2 2026 in Review

Ardsley Advisory Partners reduced its GeneDx Holdings (WGS) stake by 25% in Q2 2026, selling an estimated $1.42M and leaving 75,000 shares worth $5.15M. The position accounts for 0.54% of the portfolio, ranked #59.

Ardsley Advisory Partners first reported a position in WGS in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.38M in Q2 2025. 18 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Ardsley Advisory Partners held 75,000 shares of GeneDx Holdings worth $5.15M as of Q2 2026.
Ardsley Advisory Partners sold 25,000 GeneDx Holdings shares in Q2 2026, an estimated $1.42M.
GeneDx Holdings made up 0.54% of Ardsley Advisory Partners's portfolio in Q2 2026, its #59 holding.
Ardsley Advisory Partners first reported a position in GeneDx Holdings in Q2 2025 and has held it in 5 quarters since.
Ardsley Advisory Partners's GeneDx Holdings position peaked at $7.38M in Q2 2025.
18 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.